Gene therapy is a cutting the edge method for treatment of various diseases. Gene therapy in animal models demonstrates good potential of this treatment for curing patients with Glanzmann’s thrombasthenia. As an example for targeting transgene expression in the developing megakaryocytes from two patients with GT in vitro, αIIbβ3  promoter was expressed on these transduced megakaryocytes. CD34+ cells was demonstrated utilizing mice leukemia retrovirus vectors, by this method the Glanzmann’s thrombasthenia was corrected.
Glanzmann's thrombasthenia future or investigational therapies
Glanzmann's thrombasthenia medical therapy
Heparin-induced thrombocytopenia future or investigational therapies
Glanzmann's thrombasthenia other diagnostic studies
Glanzmann's thrombasthenia patient information
Hemophilia A future or investigational therapies
Glanzmann's thrombasthenia laboratory findings
Idiopathic thrombocytopenic purpura other diagnostic studies